Condition

Antipsychotics (1)

Aripiprazole (1)

LAI (1)

Long-Acting Injection (1)

Schizophrenia (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 4 (1)

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd. (1)

Collaborator

Intervention

abilify maintena (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

lai

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)

Completed

Schizophrenia
+4 more

Abilify maintena

Chungju, Chungcheongbuk-do, Korea, Republic of
+26 more

Dec 16, 2021